Selected article for: "Animal model and antiviral control"
Author: Cinatl, Jindrich; Michaelis, Martin; Hoever, Gerold; Preiser, Wolfgang; Doerr, Hans Wilhelm
Title: Development of antiviral therapy for severe acute respiratory syndrome
  • Cord-id: 9ujofcsm
  • Document date: 2005_4_26
    • ID: 9ujofcsm
    Snippet: A new disease, the severe acute respiratory distress syndrome (SARS), caused by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and rapidly spread throughout the world. Although the disease had disappeared in June 2003 its re-emergence cannot be excluded. The development of vaccines against SARS-CoV may take years. Therefore, the availability of effective antiviral drugs against SARS-CoV may be crucial for the control of future SARS outbreaks. In this review, experimental and c
    Document: A new disease, the severe acute respiratory distress syndrome (SARS), caused by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and rapidly spread throughout the world. Although the disease had disappeared in June 2003 its re-emergence cannot be excluded. The development of vaccines against SARS-CoV may take years. Therefore, the availability of effective antiviral drugs against SARS-CoV may be crucial for the control of future SARS outbreaks. In this review, experimental and clinical data about potential anti-SARS drugs is summarised and discussed. Animal model studies will be needed to help to determine which interventions warrant controlled clinical testing.

    Search related documents:
    Co phrase search for related documents
    • absolute bioavailability and acute respiratory syndrome: 1
    • acid compound and active catalytic site: 1
    • acid compound and active site: 1, 2
    • acid compound and acute respiratory syndrome: 1, 2, 3, 4, 5
    • active catalytic site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • active concentration and acute respiratory syndrome: 1, 2, 3, 4
    • active principle and acute respiratory distress syndrome: 1
    • active principle and acute respiratory syndrome: 1, 2
    • active site and acute respiratory distress syndrome: 1, 2
    • active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and additional pathway: 1